The first impression counts for lung function: one year to make a difference in asthma prognosis

H Pite, S Sanchez-Garcia, M Morais-Almeida

Research output: Contribution to journalArticle

Abstract

Despite being one of the most frequent chronic diseases, asthma patients live in times of hope. The introduction of regular treatment with inhaled corticosteroids (ICS) was crucial, impacting and changing the lives of several hundred million asthmatics. Advances with new molecules, whether alone or in combination, coupled with developments in inhaler technology and the advent of biologics raise the aspiration of achieving control and normalising (as opposed to optimizing) lung function, for every asthma patient. As a chronic disease without definite cure, the need for long-term real-life studies is imperative to assess clinical practice outcomes. This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)12-13
Number of pages2
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume75
Issue number1
Early online date24 Aug 2019
DOIs
Publication statusPublished - Jan 2020

Fingerprint Dive into the research topics of 'The first impression counts for lung function: one year to make a difference in asthma prognosis'. Together they form a unique fingerprint.

  • Cite this